Safety of Combined Dupilumab and Mepolizumab Therapy in Patients with Severe Asthma and Coexisting Comorbidities (ACAAI 2026) - Oct 28, 2026 - Abstract #M251; Pres time: Nov 14, 2026; 11:40 AM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 9; No abstract available
Clinical • Asthma • Immunology • Respiratory Diseases
|